Horizon Therapeutics is focused on the development of prescription drugs for mild to moderate pain relief and arthritis. read more
Horizon Therapeutics VP of Investor Relations Salary
The average Horizon Therapeutics VP of Investor Relations earns an estimated $124,538 annually. Horizon Therapeutics' VP of Investor Relations compensation is $6,870 less than the US average for a VP of Investor Relations.
Last updated 3 years ago.
$77k
$120k
$129k
$225k
$124,538
Average Compensation
- $124,538
- avg. base
VP of Investor Relations Salaries at Horizon Therapeutics
Compensation at Horizon Therapeutics by Department
How VPs of Investor Relations at Horizon Therapeutics Rate Their Compensation
The majority of VPs of Investor Relations at Horizon Therapeutics believe they're compensated fairly. 100% of VPs of Investor Relations at Horizon Therapeutics say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at Horizon Therapeutics
VP of Investor Relations Salaries at Similar Size Companies
×